Details for New Drug Application (NDA): 021673
✉ Email this page to a colleague
The generic ingredient in CLOLAR is clofarabine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clofarabine profile page.
Summary for 021673
Tradename: | CLOLAR |
Applicant: | Genzyme |
Ingredient: | clofarabine |
Patents: | 0 |
Pharmacology for NDA: 021673
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Suppliers and Packaging for NDA: 021673
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOLAR | clofarabine | SOLUTION;INTRAVENOUS | 021673 | NDA | Sanofi-Aventis U.S. LLC | 0024-5860 | 0024-5860-01 | 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) / 20 mL in 1 VIAL, SINGLE-USE |
CLOLAR | clofarabine | SOLUTION;INTRAVENOUS | 021673 | NDA AUTHORIZED GENERIC | Winthrop U.S, a business of sanofi-aventis U.S. LLC | 0955-1746 | 0955-1746-01 | 1 VIAL, SINGLE-USE in 1 BOX (0955-1746-01) / 20 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20MG/20ML (1MG/ML) | ||||
Approval Date: | Dec 28, 2004 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 021673
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Genzyme | CLOLAR | clofarabine | SOLUTION;INTRAVENOUS | 021673-001 | Dec 28, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Genzyme | CLOLAR | clofarabine | SOLUTION;INTRAVENOUS | 021673-001 | Dec 28, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Genzyme | CLOLAR | clofarabine | SOLUTION;INTRAVENOUS | 021673-001 | Dec 28, 2004 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription